The 4th Annual Scientific Meeting

The 4th Annual Scientific Meeting of the Japanese Society for Immunodeficiency and Autoinflammatory Diseases (JSIAD)

Date: February 6 (Sat)-7 (Sun), 2021

Theme:

To elucidate and utilize the fine immune function protecting our body.
– Scientific Innovation for Patients –

Venue:

Sola City Conference Center
Ochanomizu Sola City, 4-6 Kandasurugadai, Chiyoda-ku, Tokyo, 101-0062
Map

Secretariat:

Department of Child Health, Faculty of Medicine, University of Tsukuba

E-mail:

jsiad4th@md.tsukuba.ac.jp

URL:

http://jsiad-4thmeeting.kenkyuukai.jp/

Message from the Congress Chairperson


Hidetoshi TAKADA
Professor, Department of Child Health, Faculty of Medicine
University of Tsukuba


Dear Colleagues and Friends,

It is my great pleasure to make an announcement of upcoming 4th Annual Scientific Meeting of Japanese Society of Immunodeficiency and Autoinflammatory Diseases (JSIAD 4th) which is due to be held on the 6th and 7th of February 2021 at Tokyo, Japan under the theme of “To elucidate and utilize the fine immune function protecting our body: Scientific Innovation for Patients”.

JSIAD provides an opportunity to share novel findings among medical doctors, health care workers, and researchers. We also hope to serve to deliver a better treatment to patients through promoting research on pathophysiology of the diseases and evaluating new treatments to improve the quality of life of patients’ with immunodeficiency and autoinflammatory diseases. We are also committed to establish the best strategy for the use of antibiotics, vaccines, immunoglobulins, and biological agents, particularly in advanced treatments including hematopoietic stem cell transplantation and gene therapy, seeking to solve problems of complications, including infectious diseases, tumors and inflammatory bowel diseases.

I look forward to welcoming you all at the JSIAD meeting at Tokyo!

With warm regards,

Professor, Department of Child Health, Faculty of Medicine
University of Tsukuba


Call for abstracts:

Online abstract submission is scheduled to start on July 1, 2020